Growing community of inventors

Shanghai, China

Linghui Wu

Average Co-Inventor Count = 10.55

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Linghui WuHaiying He (3 patents)Linghui WuZheng Wang (3 patents)Linghui WuHongwei Li (3 patents)Linghui WuFeng Xu (3 patents)Linghui WuZhigan Jiang (3 patents)Linghui WuWeidong Li (3 patents)Linghui WuWeihua Shi (3 patents)Linghui WuMinggao Zeng (3 patents)Linghui WuKunmin Lai (3 patents)Linghui WuKevin X Chen (2 patents)Linghui WuYanxin Yu (2 patents)Linghui WuJian Li (1 patent)Linghui WuShuhui Chen (1 patent)Linghui WuFang Liu (1 patent)Linghui WuXiquan Zhang (1 patent)Linghui WuKai Zhou (1 patent)Linghui WuGuoping Hu (1 patent)Linghui WuHongjiang Xu (1 patent)Linghui WuXin Tian (1 patent)Linghui WuCheng Xie (1 patent)Linghui WuZhaoguo Chen (1 patent)Linghui WuBoyu Hu (1 patent)Linghui WuXiaofei Wang (1 patent)Linghui WuXinde Chen (1 patent)Linghui WuXiangjian Wang (1 patent)Linghui WuXiaoyuan Chen (1 patent)Linghui WuJiangfeng Lin (1 patent)Linghui WuHaomin Chen (1 patent)Linghui WuWeidong Li (0 patent)Linghui WuHaiying He (0 patent)Linghui WuHongwei Li (0 patent)Linghui WuMinggao Zeng (0 patent)Linghui WuFeng Xu (0 patent)Linghui WuWeihua Shi (0 patent)Linghui WuHaomin Chen (0 patent)Linghui WuXiaoyuan Chen (0 patent)Linghui WuZheng Wang (0 patent)Linghui WuLinghui Wu (5 patents)Haiying HeHaiying He (53 patents)Zheng WangZheng Wang (42 patents)Hongwei LiHongwei Li (33 patents)Feng XuFeng Xu (22 patents)Zhigan JiangZhigan Jiang (18 patents)Weidong LiWeidong Li (16 patents)Weihua ShiWeihua Shi (12 patents)Minggao ZengMinggao Zeng (4 patents)Kunmin LaiKunmin Lai (4 patents)Kevin X ChenKevin X Chen (29 patents)Yanxin YuYanxin Yu (5 patents)Jian LiJian Li (199 patents)Shuhui ChenShuhui Chen (196 patents)Fang LiuFang Liu (56 patents)Xiquan ZhangXiquan Zhang (42 patents)Kai ZhouKai Zhou (42 patents)Guoping HuGuoping Hu (32 patents)Hongjiang XuHongjiang Xu (27 patents)Xin TianXin Tian (16 patents)Cheng XieCheng Xie (12 patents)Zhaoguo ChenZhaoguo Chen (8 patents)Boyu HuBoyu Hu (6 patents)Xiaofei WangXiaofei Wang (6 patents)Xinde ChenXinde Chen (5 patents)Xiangjian WangXiangjian Wang (4 patents)Xiaoyuan ChenXiaoyuan Chen (1 patent)Jiangfeng LinJiangfeng Lin (1 patent)Haomin ChenHaomin Chen (1 patent)Weidong LiWeidong Li (0 patent)Haiying HeHaiying He (0 patent)Hongwei LiHongwei Li (0 patent)Minggao ZengMinggao Zeng (0 patent)Feng XuFeng Xu (0 patent)Weihua ShiWeihua Shi (0 patent)Haomin ChenHaomin Chen (0 patent)Xiaoyuan ChenXiaoyuan Chen (0 patent)Zheng WangZheng Wang (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Shandong Danhong Pharmaceutical Co., Ltd. (3 from 10 patents)

2. Medshine Discovery Inc. (2 from 65 patents)

3. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1 from 118 patents)

4. Shangdong Danhong Pharmaceutical Co., Ltd. (0 patent)


5 patents:

1. 11466024 - Bicylic compound acting as an inhibitor

2. 11117899 - [1,2,4]triazolo[1,5-c]pyrimidine derivative as Areceptor inhibitor

3. 10858322 - Process for preparing 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one

4. 10633347 - Crystal form B of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one

5. 10227309 - Crystal form A of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…